Previous 10 |
Cleveland BioLabs (NASDAQ: CBLI ): Q1 GAAP EPS of -$0.08. Revenue of $0.2M (-13.0% Y/Y) Press Release More news on: Cleveland BioLabs, Inc., Earnings news and commentary, Consumer stocks news, ,
BUFFALO, NY / ACCESSWIRE / May 15, 2019 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the first quarter ended March 31, 2019. Cleveland BioLabs reported a net loss of $(0.9) million, excluding minority interests, for the first quart...
Gainers: Atossa Genetics (NASDAQ: ATOS ) +28% . Immunic (NASDAQ: IMUX ) +22% . Akari Therapeutics (NASDAQ: AKTX ) +19% . Superconductor Technologies (NASDAQ: SCON ) +18% . X4 Pharmaceuticals (NASDAQ: XFOR ) +17% . Hasbro (NASDAQ: HAS ) +16% . Twitter (NYSE: TWTR ) +16% . Trova...
Gainers: Bio-Path Holdings (NASDAQ: BPTH ) +201% . Seelos Therapeutics (NASDAQ: SEEL ) +79% . ArQule (NASDAQ: ARQL ) +66% . Altimmune (NASDAQ: ALT ) +60% . Rosetta Stone (NYSE: RST ) +31% . Calumet Specialty Products Partners (NASDAQ: CLMT ) +29% . Cleveland BioLabs (NASDAQ: CB...
Cleveland BioLabs (NASDAQ: CBLI ): Q4 GAAP EPS of -$0.04. More news on: Cleveland BioLabs, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
BUFFALO, NY / ACCESSWIRE / March 7, 2019 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the fourth quarter and year ended December 31, 2018. Cleveland BioLabs reported a net loss of $(0.4) million, excluding minority interests, for t...
Gainers: TMSR Holding Company (NASDAQ: TMSR ) +223%. Integrated Media Technology (NASDAQ: IMTE ) +104% . Titan Pharmaceuticals (NASDAQ: TTNP ) +34%. Professional Diversity Network (NASDAQ: IPDN ) +30% . Continental Materials (NYSEMKT: CUO ) +29% . Gravity (NASDAQ: GRVY ) ...
News, Short Squeeze, Breakout and More Instantly...
Cleveland BioLabs Inc. Company Name:
CBLI Stock Symbol:
NASDAQ Market:
Cleveland BioLabs Inc. Website:
Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc." New Corporate Name and Updated Stock Ticker Symbol to Showcase Company's Post-Merger Transformation and Focus on Restoring Immune Health PR Newswire FORT COLLINS, Colo. , Aug. 31...
Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast Audio archive for the event may be accessed from the "Investors" section of the Cytocom website PR Newswire FORT COLLINS, Colo. , Aug. 16, 2021 /PRNewswire/ -- ...
Cytocom, Inc. Reports Second Quarter 2021 Financial Results -All-stock merger transaction between legacy Cleveland BioLabs and legacy Cytocom recently completed; Cytocom, Inc. common stock trading on Nasdaq as "CBLI"- -Well financed allowing multiple clinical programs that c...